ABI’s 2009 Influenza A (H1N1) purified virus products are suitable for cell culture-based infectivity assays, nucleic acid-based assays, antigen-antibody assays, antiviral resistance testing, and comparative antigenic or genomic characterization of Seasonal Influenza A (H1N1) and other Influenza A (H1N1) lineages with 2009 Influenza A (H1N1).
Safe Handling Recommendations:
This preparation contains ACTIVE VIRUS and should be handled in accordance with biosafety guidelines defined in NIH-CDC HHS publication No. (CDC) 93-8395.
